Literature DB >> 8300617

Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils.

F Porteu1, C Hieblot.   

Abstract

The effect of tumor necrosis factor alpha (TNF) on the expression of its specific receptors (p55 TNF-R and p75 TNF-R) on the surface of human neutrophils (PMN) and mononuclear cells (MNC) was investigated and compared to the effect of various agonists. PMN and MNC express both p55 and p75 TNF-R on their membranes. Within minutes of incubation with chemotactic factors or calcium ionophore A23187, both types of TNF-R were down-regulated from the surface on both cell populations. At the same time, soluble forms of these TNF-R appeared in supernatants, in amounts proportional to the extent of down-regulation induced by each stimulus, suggesting that shedding is the major mechanism leading to loss of p55 and p75 TNF-R upon activation with these agonists. Likewise, TNF induced 60-80% and 73-90% decreases in PMN surface p55 TNF-R and p75 TNF-R, respectively. However, modulation of the two types of TNF-R by TNF proceeded through different mechanisms. TNF induced a selective shedding of the p75 TNF-R since, by both enzyme-linked immunosorbent assay and Western blot analysis, only the p75 TNF-R was detected in supernatants of cells stimulated with TNF. Down-modulation of surface p55 TNF-R most probably resulted from TNF-induced receptor internalization, since 125I-TNF bound to PMN p55 TNF-R was rapidly internalized with a t1/2 = 5 min and preincubation of PMN with TNF inhibited by 68 +/- 6% the release of p55 TNF-R triggered upon subsequent treatment with A23187. The apparently unique property of TNF to induce a differential modulation of the two types of TNF-R at the surface of PMN and MNC might play an important role in the control of peripheral blood cell responses to TNF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300617

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

Authors:  Robert C Kalayjian; Rhoderick N Machekano; Nesrine Rizk; Gregory K Robbins; Rajesh T Gandhi; Benigno A Rodriguez; Richard B Pollard; Michael M Lederman; Alan Landay
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

3.  Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity.

Authors:  Shawna F Graves; Scott D Kobayashi; Kevin R Braughton; Adeline R Whitney; Daniel E Sturdevant; Devon L Rasmussen; Liliya N Kirpotina; Mark T Quinn; Frank R DeLeo
Journal:  J Leukoc Biol       Date:  2012-05-11       Impact factor: 4.962

4.  A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.

Authors:  A G Bais; I Beckmann; J Lindemans; P C Ewing; C J L M Meijer; P J F Snijders; T J M Helmerhorst
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

5.  Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.

Authors:  M Weiss; M Martignoni; T Petropoulou; B Sölder; B H Belohradsky
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

6.  In vivo expression of inflammatory cytokine receptors in the joint compartments of patients with arthritis.

Authors:  Tania Silvestri; Lia Pulsatelli; Paolo Dolzani; Luigi Frizziero; Andrea Facchini; Riccardo Meliconi
Journal:  Rheumatol Int       Date:  2005-03-16       Impact factor: 2.631

7.  Integrin stimulation regulates polymorphonuclear leukocytes inflammatory cytokine expression.

Authors:  H H Simms; R D'Amico; K I Bland
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

8.  Pharmacological analysis for mechanisms of GPI-80 release from tumour necrosis factor-alpha-stimulated human neutrophils.

Authors:  Takeaki Nitto; Yoshihiko Araki; Yuji Takeda; Fujiro Sendo
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 9.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

10.  Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.

Authors:  A P Cope; D Aderka; D Wallach; M Kahan; N R Chu; F M Brennan; M Feldmann
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.